SHC 11.5 (+3.32%)
US83601L1026Medical Diagnostics & ResearchDiagnostics & Research

Sotera Health (SHC) Competitor Comparison

We are evaluating the key criteria listed to compare Sotera Health (SHC) against its competitors in the Diagnostics & Research industry.

Linearity 5 years - SHC ranking 34 / 58

These are the competitors of Sotera Health in the industry Diagnostics & Research ranked by linearity 5 years
1. Qiagen QGEN
223.64
2. Co-Diagnostics CODX
100.26
3. DexCom DXCM
82.08
4. CareDx CDNA
65.84
5. Ortho Clinical Diagnostics Holdings OCDX
33.4
6. DarioHealth DRIO
31.71
7. Syneos Health SYNH
24.79
8. Inotiv NOTV
21.52
9. Pacific Biosciences of California PACB
16.37
10. Heska HSKA
15.42
11. Myriad Genetics MYGN
13.83
12. Exact Sciences EXAS
13.67
13. Charles River Laboratories CRL
12.34
14. Fulgent Genetics FLGT
10.84
15. Twist Bioscience TWST
10.22
16. Precipio PRPO
9.49
17. Icon ICLR
8.71
18. Olink Holding OLK
8.53
19. Guardant Health GH
8.37
20. Personalis PSNL
6.05
21. Aspira Womens Health AWH
5.9
22. PerkinElmer PKI
4.97
23. Trinity Biotech TRIB
4.91
24. IQVIA Holdings IQV
4.66
25. Agilent Technologies A
4.64
26. Danaher DHR
4.32
27. NeoGenomics NEO
4.29
28. IDEXX Laboratories IDXX
4.25
29. Psychemedics PMD
4.2
30. Anixa Biosciences ANIX
4
31. Thermo Fisher Scientific TMO
3.84
32. Illumina ILMN
3.81
33. National Research NRC
3.74
34. Sotera Health SHC
3.68
35. Mettler-Toledo MTD
3.66
36. Enzo Biochem ENZ
3.59
37. Neogen NEOG
3.27
38. Bioventus BVS
3.1
39. Exagen XGN
2.61
40. Interpace Biosciences IDXG
2.45
41. Sera Prognostics SERA
2.42
42. Waters WAT
2.37
43. Neuronetics STIM
2.28
44. Global Cord Blood CO
2.23
45. Laboratory Corp of America Holdings LH
2.17
46. Quest Diagnostics DGX
1.92
47. MDxHealth MDXH
1.91
48. MaxCyte MXCT
1.8
49. Biodesix BDSX
1.8
50. Prenetics Global PRE
1.71
51. bioAffinity Technologies BIAF
1.67
52. Organovo Holdings ONVO
1.6
53. SeqLL SQL
1.38
54. Meridian Bioscience VIVO
0.99
55. Medpace Holdings MEDP
0.83
56. Natera NTRA
0.65
57. RadNet RDNT
0.6
58. Lantheus Holdings LNTH
0.31

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.